tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Financial Statements

303 Followers

Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.638; its P/E ratio is -2.38; Relay Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 10.01M$ -1.00K$ 25.20M$ 119.00K$ 226.00K
Gross Profit$ 10.01M$ -1.00K$ 25.20M$ 119.00K$ 226.00K
EBIT$ -92.19M-$ -68.13M$ -102.81M$ -101.18M
EBITDA$ -90.80M-$ -69.65M$ -103.68M$ -102.00M
Net Income Common Stockholders$ -81.39M$ -83.50M$ -68.13M$ -98.50M$ -94.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.87M$ 143.74M$ 151.33M$ 145.90M$ 161.28M
Total Assets$ 841.44M$ 843.98M$ 906.96M$ 962.02M$ 1.04B
Total Debt$ 52.31M$ 53.47M$ 54.60M$ 55.71M$ 56.75M
Net Debt$ -100.56M$ -90.27M$ -96.73M$ -90.19M$ -104.53M
Total Liabilities$ 95.68M$ 91.98M$ 128.59M$ 151.90M$ 154.15M
Stockholders Equity$ 745.76M$ 752.00M$ 778.37M$ 810.12M$ 883.41M
Cash Flow-
Free Cash Flow$ -52.10M-$ -75.99M$ -70.10M$ -69.05M
Operating Cash Flow$ -50.32M$ -89.19M$ -75.40M$ -68.60M$ -67.13M
Investing Cash Flow$ 10.53M$ 59.68M$ 71.36M$ 51.28M$ 75.31M
Financing Cash Flow$ 48.92M$ 21.92M$ 9.46M$ 2.08M$ 1.30M
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis